IBEX Enhanced X-ray Mammography

该项目将开发新技术并将其商业化，以从根本上提高X光乳房成像的安全性、有效性和患者舒适性。首先，该项目将采用IBEX TrueView(R)无网格散射校正方法，用于乳房X光照相和数字乳房断层扫描(DBT)系统，并证明其在减少患者剂量和提高乳房X光照相和DBT重建图像质量方面的有效性。在这一初始阶段产生的体内和体外数据将被用来向领先的医疗X射线系统集成商推销这一能力，并在项目的第一年内获得商业许可交易。第二，该项目将开发和展示一种原型3D X射线成像系统的有效性，该系统能够以比标准2D乳房X光照相更少的患者剂量创建完整的、高对比度的未压缩乳房的3D重建，并且无需注射造影剂。这种激进的新产品有可能改变乳房筛查和癌症诊断，特别是对乳房致密的女性。在这第二阶段收集的体外数据将被用来为商业化战略和未来的人类临床研究提供参考。“

"The project will develop and commercialise novel technologies to radically improve the safety, effectiveness and patient comfort of X-ray breast imaging.Firstly, the project will adapt the IBEX Trueview(r) gridless scatter correction method for use in mammography and Digital Breast Tomosynthesis (DBT) systems and demonstrate its effectiveness to reduce patient dose and improve image quality in mammograms and DBT reconstructions. The in-vivo and ex-vivo data generated during this initial phase will be used to market the capability to leading medical X-ray system integrators and secure commercial licence deals within the first year of the project.Secondly, the project will develop and demonstrate the effectiveness of a prototype 3D X-ray imaging system capable of creating full, high-contrast 3D reconstructions of uncompressed breasts at less patient dose than a standard 2D mammogram and without injected contrast agents. This radical new product has the potential to transform breast screening and cancer diagnosis, especially for women with dense breasts. The ex-vivo data collected during this second phase will be used to inform a commercialisation strategy and a future human clinical study."